{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T16:39:58Z","timestamp":1790786398646,"version":"4.1.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,10,30]],"date-time":"2019-10-30T00:00:00Z","timestamp":1572393600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["16H01386"],"award-info":[{"award-number":["16H01386"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["18H04696"],"award-info":[{"award-number":["18H04696"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["17K19722"],"award-info":[{"award-number":["17K19722"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["17H04008"],"award-info":[{"award-number":["17H04008"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007428","name":"Naito Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007428","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013225","name":"Academy of Scientific and Innovative Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013225","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmacological Sciences"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1016\/j.jphs.2019.10.005","type":"journal-article","created":{"date-parts":[[2019,11,4]],"date-time":"2019-11-04T02:16:40Z","timestamp":1572833800000},"page":"131-138","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["Improvement of peripheral vascular impairment by a phosphodiesterase type 5 inhibitor tadalafil prevents oxaliplatin-induced peripheral neuropathy in mice"],"prefix":"10.1016","volume":"141","author":[{"given":"Takashi","family":"Ogihara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takayuki","family":"Nakagawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maho","family":"Hayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madoka","family":"Koyanagi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Yonezawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomohiro","family":"Omura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunsaku","family":"Nakagawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noriaki","family":"Kitada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Imai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuo","family":"Matsubara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl 1","key":"10.1016\/j.jphs.2019.10.005_bib1","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1097\/j.pain.0000000000001540","article-title":"Chemotherapy-induced peripheral neuropathy: where are we now?","volume":"160","author":"Colvin","year":"2019","journal-title":"Pain"},{"key":"10.1016\/j.jphs.2019.10.005_bib2","first-page":"2397","article-title":"Changes in upper extremity function, ADL, and HRQoL in colorectal cancer patients after the first chemotherapy cycle with oxaliplatin: a prospective single-center observational study","volume":"26","author":"Tabata","year":"2018","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.jphs.2019.10.005_bib3","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1093\/bja\/aex229","article-title":"Clinical and preclinical perspectives on Chemotherapy-Induced Peripheral Neuropathy (CIPN): a narrative review","volume":"119","author":"Flatters","year":"2017","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.jphs.2019.10.005_bib4","doi-asserted-by":"crossref","first-page":"184","DOI":"10.2174\/1570159X15666170915143217","article-title":"Prevention and treatment for chemotherapy-induced peripheral neuropathy: therapies based on CIPN mechanisms","volume":"17","author":"Hu","year":"2019","journal-title":"Curr Neuropharmacol"},{"key":"10.1016\/j.jphs.2019.10.005_bib5","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/B978-0-444-53480-4.00023-0","article-title":"Ischemia and diabetic neuropathy","volume":"126","author":"Nukada","year":"2014","journal-title":"Handb Clin Neurol"},{"key":"10.1016\/j.jphs.2019.10.005_bib6","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1900\/RDS.2015.12.13","article-title":"Vascular impairment of epineurial arterioles of the sciatic nerve: implications for diabetic peripheral neuropathy","volume":"12","author":"Yorek","year":"2015","journal-title":"Rev Diabet Stud"},{"key":"10.1016\/j.jphs.2019.10.005_bib7","doi-asserted-by":"crossref","first-page":"655","DOI":"10.2337\/dc06-2154","article-title":"Impaired skin microvascular reactivity in painful diabetic neuropathy","volume":"30","author":"Quattrini","year":"2007","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jphs.2019.10.005_bib8","doi-asserted-by":"crossref","first-page":"2648","DOI":"10.2337\/dc10-0456","article-title":"Low peripheral nerve conduction velocities and amplitudes are strongly related to diabetic microvascular complications in type 1 diabetes: the EURODIAB Prospective Complications Study","volume":"33","author":"Charles","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jphs.2019.10.005_bib9","article-title":"An early diagnostic tool for diabetic peripheral neuropathy in rats","volume":"10","author":"Kambiz","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jphs.2019.10.005_bib10","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.pain.2008.03.027","article-title":"Characteristics of chronic ischemic pain in patients with peripheral arterial disease","volume":"139","author":"R\u00fcger","year":"2008","journal-title":"Pain"},{"key":"10.1016\/j.jphs.2019.10.005_bib11","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1111\/j.1533-2500.2011.00460.x","article-title":"25. Ischemic pain in the extremities and Raynaud's phenomenon","volume":"11","author":"Devulder","year":"2011","journal-title":"Pain Pract"},{"key":"10.1016\/j.jphs.2019.10.005_bib12","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1038\/nrrheum.2014.195","article-title":"A\u00a0vascular mechanistic approach to understanding Raynaud phenomenon","volume":"11","author":"Flavahan","year":"2015","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.jphs.2019.10.005_bib13","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1006\/exnr.2000.7373","article-title":"Development of a mouse model of neuropathic pain following photochemically induced ischemia in the sciatic nerve","volume":"163","author":"Hao","year":"2000","journal-title":"Exp Neurol"},{"key":"10.1016\/j.jphs.2019.10.005_bib14","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.pain.2004.08.001","article-title":"Chronic post-ischemia pain (CPIP): a novel animal model of complex regional pain syndrome-Type I (CRPS-I; reflex sympathetic dystrophy) produced by prolonged hindpaw ischemia and reperfusion in the rat","volume":"112","author":"Coderre","year":"2004","journal-title":"Pain"},{"key":"10.1016\/j.jphs.2019.10.005_bib15","doi-asserted-by":"crossref","first-page":"23261","DOI":"10.1038\/srep23261","article-title":"Hypoxia-induced sensitization of TRPA1 in painful dysesthesia evoked by transient hindlimb ischemia\/reperfusion in mice","volume":"6","author":"So","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.jphs.2019.10.005_bib16","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1007\/BF00400579","article-title":"Effect of cilostazol on experimental diabetic neuropathy in the rat","volume":"38","author":"Kihara","year":"1995","journal-title":"Diabetologia"},{"key":"10.1016\/j.jphs.2019.10.005_bib17","article-title":"Sildenafil ameliorates long term peripheral neuropathy in type II diabetic mice","volume":"10","author":"Wang","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jphs.2019.10.005_bib18","article-title":"Tadalafil promotes the recovery of peripheral neuropathy in type II diabetic mice","volume":"11","author":"Wang","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.jphs.2019.10.005_bib19","doi-asserted-by":"crossref","first-page":"726","DOI":"10.2337\/diab.40.6.726","article-title":"Amelioration of nerve Na+-K+-ATPase activity independently of myo-inositol level by PGE1 analogue OP-1206.alpha-CD in streptozocin-induced diabetic rats","volume":"40","author":"Sonobe","year":"1991","journal-title":"Diabetes"},{"key":"10.1016\/j.jphs.2019.10.005_bib20","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1007\/BF00399794","article-title":"The potential contribution of endothelin-1 to neurovascular abnormalities in streptozotocin-diabetic rats","volume":"37","author":"Cameron","year":"1994","journal-title":"Diabetologia"},{"key":"10.1016\/j.jphs.2019.10.005_bib21","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1254\/jphs.08325SC","article-title":"Effects of the prostaglandin E1 analog limaprost on mechanical allodynia caused by chemotherapeutic agents in mice","volume":"109","author":"Gauchan","year":"2009","journal-title":"J\u00a0Pharmacol Sci"},{"key":"10.1016\/j.jphs.2019.10.005_bib22","doi-asserted-by":"crossref","first-page":"16078","DOI":"10.1038\/srep16078","article-title":"Preventive effect of oral goshajinkigan on chronic oxaliplatin-induced hypoesthesia in rats","volume":"5","author":"Kono","year":"2015","journal-title":"Sci Rep"},{"key":"10.1016\/j.jphs.2019.10.005_bib23","doi-asserted-by":"crossref","first-page":"5955","DOI":"10.1158\/0008-5472.CAN-14-2060","article-title":"A\u00a0quantitative sensory analysis of peripheral neuropathy in colorectal cancer and its exacerbation by oxaliplatin chemotherapy","volume":"74","author":"de Carvalho Barbosa","year":"2014","journal-title":"Cancer Res"},{"key":"10.1016\/j.jphs.2019.10.005_bib24","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1111\/cas.13010","article-title":"Quantitative assessment of chemotherapy-induced peripheral neurotoxicity using a point-of-care nerve conduction device","volume":"107","author":"Matsuoka","year":"2016","journal-title":"Cancer Sci"},{"key":"10.1016\/j.jphs.2019.10.005_bib25","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1016\/S0959-8049(01)00300-8","article-title":"Effects of different schedules of oxaliplatin treatment on the peripheral nervous system of the rat","volume":"37","author":"Cavaletti","year":"2001","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.jphs.2019.10.005_bib26","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.tox.2007.02.013","article-title":"Behavioral and immunohistological assessment of painful neuropathy induced by a single oxaliplatin injection in the rat","volume":"234","author":"Ling","year":"2007","journal-title":"Toxicology"},{"key":"10.1016\/j.jphs.2019.10.005_bib27","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.pain.2009.09.003","article-title":"Oxaliplatin induced neuropathy in the rat: involvement of oxalate in cold hyperalgesia but not mechanical allodynia","volume":"147","author":"Sakurai","year":"2009","journal-title":"Pain"},{"key":"10.1016\/j.jphs.2019.10.005_bib28","doi-asserted-by":"crossref","first-page":"309","DOI":"10.2174\/1567202613666160601144254","article-title":"TRPA1 and TRPM8 receptors may promote local vasodilation that aggravates oxaliplatin-induced peripheral neuropathy amenable to 17\u03b2-estradiol treatment","volume":"13","author":"Pan","year":"2016","journal-title":"Curr Neurovascular Res"},{"key":"10.1016\/j.jphs.2019.10.005_bib29","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s00280-011-1669-x","article-title":"5-Fluorouracil-based therapy induces endovascular injury having potential significance to development of clinically overt cardiotoxicity","volume":"69","author":"Jensen","year":"2012","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.jphs.2019.10.005_bib30","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.jhep.2013.04.014","article-title":"Pathogenesis of FOLFOX induced sinusoidal obstruction syndrome in a murine chemotherapy model","volume":"59","author":"Robinson","year":"2013","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jphs.2019.10.005_bib31","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/1744-8069-8-55","article-title":"Acute cold hypersensitivity characteristically induced by oxaliplatin is caused by the enhanced responsiveness of TRPA1 in mice","volume":"8","author":"Zhao","year":"2012","journal-title":"Mol Pain"},{"key":"10.1016\/j.jphs.2019.10.005_bib32","doi-asserted-by":"crossref","first-page":"12840","DOI":"10.1038\/ncomms12840","article-title":"Cold sensitivity of TRPA1 is unveiled by the prolyl hydroxylation blockade-induced sensitization to ROS","volume":"7","author":"Miyake","year":"2016","journal-title":"Nat Commun"},{"key":"10.1016\/j.jphs.2019.10.005_bib33","doi-asserted-by":"crossref","first-page":"878","DOI":"10.3389\/fphys.2017.00878","article-title":"Distinct mechanism of cysteine oxidation-dependent activation and cold sensitization of human transient receptor potential ankyrin 1 channel by high and low oxaliplatin","volume":"8","author":"Miyake","year":"2017","journal-title":"Front Physiol"},{"key":"10.1016\/j.jphs.2019.10.005_bib34","doi-asserted-by":"crossref","DOI":"10.1177\/1744806918789812","article-title":"TRPA1 sensitization during diabetic vascular impairment contributes to cold hypersensitivity in a mouse model of painful diabetic peripheral neuropathy","volume":"14","author":"Hiyama","year":"2018","journal-title":"Mol Pain"},{"key":"10.1016\/j.jphs.2019.10.005_bib35","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1200\/JCO.2013.54.0914","article-title":"Prevention and management of chemotherapy-induced peripheral neuropathy in survivors of adult cancers: American Society of Clinical Oncology clinical practice guideline","volume":"32","author":"Hershman","year":"2014","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jphs.2019.10.005_bib36","first-page":"131","article-title":"Slowing of motor nerve conduction velocity in streptozotocin-induced diabetic rats is preceded by impaired vasodilation in arterioles that overlie the sciatic nerve","volume":"1","author":"Coppey","year":"2000","journal-title":"Int J Exp Diabetes Res"},{"key":"10.1016\/j.jphs.2019.10.005_bib37","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1161\/01.RES.0000102937.50486.1B","article-title":"Cell type-specific regulation of angiogenic growth factor gene expression and induction of angiogenesis in nonischemic tissue by a constitutively active form of hypoxia-inducible factor 1","volume":"93","author":"Kelly","year":"2003","journal-title":"Circ Res"},{"key":"10.1016\/j.jphs.2019.10.005_bib38","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/bs.irn.2019.05.001","article-title":"Mitochondrial dysfunction in the pathogenesis of chemotherapy-induced peripheral neuropathy","volume":"145","author":"Trecarichi","year":"2019","journal-title":"Int Rev Neurobiol"},{"key":"10.1016\/j.jphs.2019.10.005_bib39","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1111\/1440-1681.12803","article-title":"The use of antioxidant agents for chemotherapy-induced peripheral neuropathy treatment in animal models","volume":"44","author":"Carvalho","year":"2017","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"10.1016\/j.jphs.2019.10.005_bib40","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1093\/jnci\/djx178","article-title":"Effects of cryotherapy on objective and subjective symptoms of paclitaxel-induced neuropathy: prospective self-controlled trial","volume":"110","author":"Hanai","year":"2018","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.jphs.2019.10.005_bib41","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s10549-016-3977-7","article-title":"Evaluation of the effect of compression therapy using surgical gloves on nanoparticle albumin-bound paclitaxel-induced peripheral neuropathy: a phase II multicenter study by the Kamigata Breast Cancer Study Group","volume":"160","author":"Tsuyuki","year":"2016","journal-title":"Breast Canc Res Treat"}],"container-title":["Journal of Pharmacological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1347861319357238?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1347861319357238?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T23:13:47Z","timestamp":1778800427000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1347861319357238"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":41,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["S1347861319357238"],"URL":"https:\/\/doi.org\/10.1016\/j.jphs.2019.10.005","relation":{},"ISSN":["1347-8613"],"issn-type":[{"value":"1347-8613","type":"print"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Improvement of peripheral vascular impairment by a phosphodiesterase type 5 inhibitor tadalafil prevents oxaliplatin-induced peripheral neuropathy in mice","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmacological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jphs.2019.10.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Production and hosting by Elsevier B.V. on behalf of Japanese Pharmacological Society.","name":"copyright","label":"Copyright"}]}}